Indivior Director Increases Shareholding, Signaling Confidence

The latest update is out from Indivior ( (GB:INDV) ).

Indivior PLC announced that Dr. Keith Humphreys, a Non-Executive Director, acquired 1,500 ordinary shares of the company at an average price of $9.149 per share, increasing his total shareholding to 3,879 shares. This transaction, conducted on the Nasdaq Global Select Market, reflects ongoing confidence in the company’s market position and strategic direction, potentially influencing stakeholder perceptions positively.

More about Indivior

Indivior PLC operates in the pharmaceutical industry, focusing on the development and distribution of medications primarily for addiction treatment. The company is known for its innovative products aimed at addressing substance use disorders and related mental health issues.

YTD Price Performance: -30.32%

Average Trading Volume: 334,440

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: £889.4M

For an in-depth examination of INDV stock, go to TipRanks’ Stock Analysis page.